Stock Picks: Banks, Brokerages & Healthcare

Brooke Sopelsa, |Video Producer
Thursday, 20 Mar 2008 | 3:06 PM ET

Spring is finally here, and CNBC asked the experts how investors can best position their portfolios before the long weekend ahead.

Your Best Trades Now
Making money in banks and brokerages, with Jeff Krumpelman, Fifth Third Asset Management senior portfolio manager and CNBC's Becky Quick

Going for Banks & Brokerages

We would favor, I think, the banks and the diversified financials — the more diversified models, like a JPMorgan — but I would also be looking at well-capitalized brokers that have executed through this. Lehman is an example I think that folks [feared] going into the week, but that’s an example of a name that I think I would own.”

- Jeff Krumpelman, Fifth Third Asset Management Sr. Portfolio Manager

Spots to Profit Now
Places where your money is still safe, with John Miller Nuveen Asset Manager; Owen Fitzpatrick, Deutsche Bank Private Wealth Management and CNBC's Becky Quick

Playing Defense With Healthcare

Healthcare really hasn’t participated here as a defensive area yet. When you look at the earnings numbers, when you look at the product flow, when you look at topline growth, and you don’t have to reset the bar in terms of bringing earnings down, we think healthcare really makes sense. And in certain areas like device companies, service companies, [those] really are very defensive names here.

- Owen Fitzpatrick, Deutsche Bank Private Wealth Management

Fitzpatrick recommends: Stryker, Zimmer, Smith & Nephew, Medtronic, St. Jude Medical.

The Good Friday Trade
The best ways to play the market, with Arthur Cashin, UBS Financial Services; Todd Leone, Cowen and Company and CNBC's Mark Haines

Betting on Big-Cap Pharma

I like the healthcare sector, in particular big-cap pharmas. I like the med techs and the hospital supply stocks. I think in the big cap area, stocks have underperformed. They’re down about 13 percent for the year, and they pay a nice dividend. If you look at the Treasury yields, you probably get three to five percent. You can get that in big-cap pharmas, plus you have a chance for price appreciation. They have a lot of cash on their balance sheets, and they’re safety plays.

- Todd Leone, Cowen & Co.

  Price   Change %Change


Contact Stocks


    Get the best of CNBC in your inbox

    › Learn More